Salt. That’s what most customers expect to find sprinkled on their fast food french fries. Yet, an Ohio woman says she recently received an order of fries from Wendy’s covered in something else: marijuana. [More]
drugs
Woman Claims Young Daughter Received Wendy’s Fries Dusted In Marijuana
By 10.12.16 — Updated: 10.13.16
Pharmaceutical Companies Accused Of Colluding To Delay Generic Version Of Popular Cholesterol Drug
By 10.10.16
If you’ve got a patent-protected drug that’s bringing in more than $1 billion a year in sales, you stand to lose a significant chunk of that revenue when the patent expires and lower-cost generic versions come on the market. A California prosecutor alleges that a number of drug companies illegally colluded in a nearly decade-long “pay-for-delay” deal intended to prevent the release of a cheaper competitor to a popular cholesterol drug. [More]
Mylan To Pay $465M To Settle EpiPen Medicaid Pricing Scandal; Critics Call Deal “Inadequate”
By 10.7.16 — Updated: 10.24.16
Amid recent revelations that EpiPen maker Mylan has been overcharging U.S. taxpayers for potentially hundreds of millions of dollars since at least 2011, the drug company says it has agreed to pay $465 million to close the book on a federal investigation into its Medicaid pricing — all without admitting any liability. [More]
After Confusion Over EpiPen Profits, Lawmakers Want Proof Of Drug’s Actual Costs
By 10.3.16
When Mylan CEO Heather Bresch recently testified before the House Oversight Committee, she claimed that the company only made $50 per EpiPen, in spite of charging $608 per two-pack of the emergency allergy medicine. Mylan then said it makes around $80/EpiPen — a figure that lawmakers still doubted. Now the leadership of the Oversight Committee is asking Mylan to clear things up for everyone by turning over documents that actually show how much the company makes from EpiPen. [More]
HSN Apparently Not Happy With “Skincare Solutions” Doctor Accused Of Buying Drugs
By 9.28.16
If you’re in the market for skincare products from the Home Shopping Network, you might be out of luck, as the company removed every trace of well-known host Dr. Sheldon Sevinor — and his products — from its website after the plastic surgeon’s arrest for allegedly buying cocaine. [More]
Senators Ask DOJ To Investigate Mylan Over Possible EpiPen Medicaid Fraud
By 9.28.16
EpiPen maker Mylan might have thought that dealing with the public shaming of a congressional hearing would be the low point of its ongoing price-hike scandal, but lawmakers continue to scrutinize the drug company and are now calling for a federal investigation into the possibility that Mylan was deliberately mis-categorizing the emergency allergy medication in order to reap bigger payments from Medicaid. [More]
West Virginia Investigating EpiPen Maker Mylan For Alleged Medicaid Fraud, Antitrust Violations
By 9.20.16
On the eve of a Congressional hearing on the soaring price and lack of competition for the EpiPen emergency allergy treatment, the attorney general for West Virginia has confirmed his office is investigating EpiPen maker Mylan for allegations of antitrust violations and Medicaid fraud. [More]
CEO Of EpiPen Maker Mylan To Face Congressional Hearing Next Week
By 9.14.16
In recent weeks, members of both the House and Senate have raised questions about the soaring price of — and potential antitrust concerns surrounding — emergency allergy treatment EpiPen. A congressional committee confirmed this morning that it will soon hold a hearing on the issue, and that Heather Bresch, CEO of EpiPen maker Mylan, has been called to testify. [More]
New York Launches Antitrust Investigation Into EpiPen Schools Program
By 9.6.16
Amid calls for drugmaker Mylan to drop the price of emergency allergy treatment EpiPen, the attorney general for the state of New York has launched an antitrust investigation into a program that helps to put EpiPens in schools, potentially to the detriment of competition. At the same time, U.S. lawmakers are pushing regulators for a federal antitrust probe on the program. [More]
Police: 600 Marijuana Plants Found In Day Care Center’s Backyard
By 9.6.16
While it’s always nice to have a backyard for children to play, some kinds of greenery should be kept far from the clutches of kids. Like the 600 marijuana plants police in Connecticut say they found in the yard of a day care center. [More]
Heroin Mixed With Powerful Animal Tranquilizer Linked To Spike In Overdoses In Ohio
By 9.6.16
A sharp increase in heroin overdoses in the Cincinnati area — more than 200 in the last two weeks, killing three — has medical and law enforcement officials on edge. One possible culprit for the uptick? A super strong synthetic animal tranquilizer called carfentanil. [More]
11-Year-Old Finds Bag Of Meth Inside Video Game He Bought At GameStop
By 9.2.16
Unexpected freebies that come with a purchase are one thing, but bags filled with meth stashed in a video game case, well, that’s a case for law enforcement. [More]
Senator: EpiPen Generic Announcement “Raises As Many Questions As Solutions”
By 8.29.16
This morning, drug company Mylan announced that it will soon introduce a lower-cost (but still not cheap) generic version of its popular EpiPen emergency allergy treatment. In response, one senator who has been critical of Mylan’s actions says more must be done to make the life-saving drug available. [More]
Mylan To Sell Generic EpiPen Pack… For Only $300
By 8.29.16
Facing criticism from patients, consumer advocates, lawmakers, and physicians about huge price increases on the EpiPen emergency allergy treatment, drugmaker Mylan today announced it will introduce a generic version of the epinephrine auto-injector for half the current sticker price of the name-brand drug. [More]
Pediatricians Call On Mylan To Make EpiPens More Affordable
By 8.26.16
Following reports on the skyrocketing cost of the EpiPen emergency allergy treatment, drugmaker Mylan has been heavily criticized for putting profit over patients. Even the recent expansion of its savings card program has been slammed as being more beneficial to Mylan than it is for consumers. Now, the nation’s largest group of pediatricians are calling on the company to rethink its pricing of the drug. [More]
6 Things You Should Know About Heather Bresch, The CEO Behind EpiPen Price Hike
By 8.24.16
As you may have heard, the cost of a life-saving EpiPen from drug maker Mylan increased as much as 600% in just nine years, causing lawmakers and health advocates to call on the drug company — and its CEO Heather Bresch — to lower the cost and provide answers for its increase in the first place. But that could be difficult given the executive’s personal connections not only to the medication, but one legislator. [More]
Senators Demand Mylan Lower Cost Of Life-Saving Epipens, Call For Congressional Hearing
By 8.23.16
The cost of a life-saving EpiPen from drug maker Mylan increased as much as 600% in just nine years. That’s simply too much, lawmakers say, with some legislators now calling on the pharmaceutical giant to drop its price immediately, while others are pushing for a congressional hearing on the matter. [More]
DEA Denies Governors’ Petitions To Reclassify Marijuana For Medical Use
By 8.11.16 — Updated: 2.23.17
Half the states and the District of Columbia have passed laws legalizing the use of marijuana for medical purposes, but the plant remains an illegal, Schedule I drug on the federal level. Five years after the governors of Rhode Island and Washington petitioned the Drug Enforcement Administration to reconsider this classification, the DEA has denied their requests. [More]
